Hepatic Infarction after Transjugular Intrahepatic Shunt Creation.

J Vasc Interv Radiol

Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India. Electronic address:

Published: October 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2021.06.004DOI Listing

Publication Analysis

Top Keywords

hepatic infarction
4
infarction transjugular
4
transjugular intrahepatic
4
intrahepatic shunt
4
shunt creation
4
hepatic
1
transjugular
1
intrahepatic
1
shunt
1
creation
1

Similar Publications

Tuberculous meningitis (TBM) is predominantly observed in developing countries but remains relatively rare in developed countries. Therefore, if a clinician does not suspect TBM, its diagnosis may be delayed. Furthermore, drug-induced hepatotoxicity is common and can become severe during TBM treatment.

View Article and Find Full Text PDF

Oral contraceptives (OCs) containing estrogen and/or progesterone are the second most common form of female contraception in the United States. While endogenously synthesized estrogen is known to provide protective effects against cardiometabolic diseases, exogenous forms such as OCs have been linked to increased susceptibility to cardiometabolic diseases and an elevated risk of myocardial infarction. The gut microbiota is thought to be a critical regulator of cardiometabolic disease risk; however, its interactions with OC use remain understudied.

View Article and Find Full Text PDF

Chikungunya virus (CHIKV) is globally distributed and transmitted by Aedes mosquitoes, with a mortality rate of 0.8/1,000 cases. The heart is the second most affected organ, with the osteoarticular system being the first.

View Article and Find Full Text PDF

Myocardial infarction is a major disease that seriously jeopardizes human health, and patients with comorbid metabolic disorders usually have a faster progression and worse prognosis. The presence of metabolic dysfunction-associated fatty liver disease not only exacerbates insulin resistance and metabolic imbalance but also contributes to the progression of myocardial infarction in a multifaceted and multifaceted manner through interactions with peripheral adipose tissue, the intestinal microbiota, and epigenetic alterations, as well as "direct communication" between the heart and the liver. Both physiologically and pathologically, it is of interest to note that cross-organ "direct communication" between the heart and the liver can occur in a variety of ways through a variety of means, including extracellular vesicles.

View Article and Find Full Text PDF

Background And Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) has recently replaced non-alcoholic fatty liver disease (NAFLD) as the preferred nomenclature, reflecting a shift toward inclusion-based diagnostic criteria rooted in metabolic dysfunction. Beyond its hepatic implications, MASLD has emerged as an independent, modifiable driver of cardiovascular disease (CVD).

Methods: This review summarizes and synthesizes robust epidemiological and mechanistic evidence linking MASLD to cardiovascular outcomes.

View Article and Find Full Text PDF